To investigate the effect of APOL1 genotype in cardiovascular diseases, we established and characterized a mouse model, by crossing ApoE knock-out mice and BAC/APOL1 mice carrying the APOL1-G0 or APOL1-G1 variant controlled by the human APOL1 gene locus promotor. This evidence concerns the gene APOL1 and cardiovascular disorder.